─── Case Studies
Real examples of how data governance, BI modernization, and analytics leadership create measurable business value — in margin, cost, decision speed, and time saved.
● Case 01
Leadership knew inflationary pressure was eating into margins — but they couldn't see exactly where or by how much. Without visibility into supplier performance and cost trends, purchasing decisions were being made on instinct rather than data.
By designing analytics models and dashboards focused on cost trends and supplier-related insights, the leadership team could see purchasing patterns clearly for the first time. That visibility translated directly into better negotiating positions, smarter sourcing decisions, and measurable cost reduction.
What made the difference
● Case 02
Fragmented commercial data across five business units made it nearly impossible to see where margins were growing and where they were quietly being lost. Customer profitability looked fine at the surface level — until you looked by customer, by channel, and by segment.
By building a consolidated customer profitability model and commercial sales data foundation across all five business units, leadership finally had an accurate view of profit at the level that actually drives pricing and commercial decisions.
What made the difference
● Case 03
The monthly close was a manual grind. Spreadsheet consolidation, data reconciliation, and reformatting — all before anything useful could reach the leadership team or the bank. The process was slow, error-prone, and entirely dependent on a small number of people who knew how it worked.
By designing and deploying an automated Asset Securitization financial reporting model, the monthly reporting cycle shortened dramatically. Accuracy improved, the dependency on manual processes was eliminated, and leadership got cleaner, faster access to the numbers they needed.
What made the difference
● Case 04
For a life sciences consulting engagement, the challenge was comparing drug side effect data across sources that used inconsistent terminology. Without a common framework, analysts couldn't tell whether a pattern in the data reflected a likely true drug effect or simply an inconsistency in how claims were being coded and reported across different sources.
By developing a QlikView pharmacovigilance dashboard that aligned claims to preferred standard terms and used alternate states for side-by-side source comparison, analysts gained a reliable analytical framework for interpreting side effect signals.
What made the difference
─── Industries behind the work
These engagements span manufacturing, supply chain, finance, commercial operations, and life sciences. Messy data, unclear ownership, inconsistent KPIs, and leadership teams that couldn't fully trust what they were looking at.
🏭
─── Two ways to start ───
Either call gets you a straight conversation — no pitch deck, no pressure.
